G24 25
Pill imprint G24 25 has been identified as Zonisamide 25 mg.
Zonisamide is used in the treatment of seizures; migraine prevention; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy.
Zonisamide 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Zonisamide Images
- Imprint:
-
G24
25 - Strength:
- 25 mg
- Color:
- Blue & White
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
sodium lauryl sulfate
gelatin
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0128
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0190 | Amerisource Health Services |
| 35356-0093 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Zonisamide resources
- Zonisamide (Wolters Kluwer)
- zonisamide (Cerner Multum)
- zonisamide (Micromedex) - Includes Dosage Information
- Zonisamide (AHFS DI)
- Zonisamide Capsules (FDA)
- Zonisamide (Wolters Kluwer)
Search Again
